News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
272 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (244)
2 (297)
3 (283)
4 (339)
5 (117)
6 (2)
7 (10)
8 (276)
9 (272)
10 (235)
11 (303)
12 (110)
13 (2)
14 (3)
15 (218)
16 (173)
17 (185)
18 (189)
19 (117)
21 (4)
22 (161)
23 (232)
24 (193)
25 (188)
26 (72)
27 (3)
28 (5)
29 (171)
30 (179)
31 (179)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
21
22
23
24
25
26
27
28
29
30
31
“Symptoms of a Sick Earth": Study Illuminates Impact of Climate Change on Infectious Disease
A study was recently published in Nature Climate Change showing that climate change is making more than half of hundreds of known infectious diseases worse.
August 9, 2022
·
4 min read
·
Mark Terry
Digital Therapeutics can Increase Value of Disease-Modifying Drugs
Biogen and others are seeing the value in, particularly, non-prescription digital therapeutics, as complementary companion therapies to disease-modifying drugs.
August 9, 2022
·
5 min read
·
Gail Dutton
Drug Development
BeiGene and Novartis’s Tislelizumab Makes Late-Stage Progress against Liver Cancer
BeiGene and Novartis’ unresectable hepatocellular carcinoma treatment, Tislelizumab, is gaining ground as a potential treatment for advanced liver cancer.
August 9, 2022
·
2 min read
·
Vanessa Doctor, MS
Business
Novavax Hit Hard by Late Vaccine, while BioNTech Touts Variant-Adapted Shots
Novavax released its second quarter financial results, showing a dramatic adjustment in its sales outlook, while BioNTech prepares to launch two variant-adopted bivalent shots.
August 9, 2022
·
3 min read
·
Tristan Manalac
Business
J&J’s Mathai Mammen Abruptly Departs in Latest Leadership Jolt
Five years after joining Johnson & Johnson as head of research and development, Mathai Mammen is leaving abruptly to seek other opportunities outside the company.
August 9, 2022
·
2 min read
·
Alex Keown
Employer Resources
How to Make the Most of In-Person Networking Events as an Employer
Attending a networking event isn’t enough – you have to make the most of it. To be successful, you need to be strategic about who you talk to, what you say, and how you follow up to get the best candidates.
August 9, 2022
·
4 min read
·
Franklin Carpenter
Business
GSK Ups Ante in ADC Discovery Game with $1.4B Mersana Option Deal
Mersana unveiled a global collaboration with GSK, which gives GSK the exclusive option to co-develop and commercialize Mersana’s antibody-drug conjugate XMT-2056.
August 9, 2022
·
3 min read
·
Tristan Manalac
Job Trends
Biogen Expected to Cut Costs by $1B as Industry Braves Economic Instability
Biogen expects to lay off a potential 1,000 staffers in an effort to cut about $1 billion in costs, according to The Boston Globe, while 10x Genomics and Talis Biomedical also cut staff.
August 9, 2022
·
4 min read
·
Mark Terry
Employer Resources
A Comprehensive Guide to Diversity, Equity and Inclusion Leadership
As organizations implement diversity initiatives, they often need a leader to guide them in the right direction. Find out what DEI leadership is and how it can help your business in our guide.
August 9, 2022
·
4 min read
·
Rosemary Scott
Drug Development
Verona, Daiichi Sankyo, AstraZeneca and Kodiak Score Big Wins in Key Diseases
The week started off with a clinical bang for Verona Pharma, Kodiak, AstraZeneca and Daiichi Sankyo with wins in COPD, lung cancer and macular edema respectively.
August 9, 2022
·
3 min read
·
Vanessa Doctor, RN
1 of 28
Next